MIRATI THERAPEUTICS INC's ticker is MRTX and the CUSIP is 60468T105. A total of 247 filers reported holding MIRATI THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.35 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $276,000 | -83.9% | 1,558 | -85.3% | 0.00% | -85.7% |
| Q2 2021 | $1,712,000 | -95.9% | 10,595 | -95.6% | 0.01% | -95.9% |
| Q1 2021 | $41,429,000 | -55.3% | 241,849 | -42.7% | 0.17% | -59.2% |
| Q4 2020 | $92,651,000 | +3346.8% | 421,832 | +2506.8% | 0.42% | +2382.4% |
| Q3 2020 | $2,688,000 | +4.3% | 16,182 | -51.7% | 0.02% | -15.0% |
| Q1 2020 | $2,577,000 | +26.9% | 33,529 | +70.1% | 0.02% | +53.8% |
| Q2 2019 | $2,030,000 | -93.3% | 19,708 | -97.0% | 0.01% | -87.6% |
| Q3 2018 | $30,502,000 | -23.1% | 647,586 | -19.5% | 0.10% | -53.1% |
| Q2 2018 | $39,675,000 | +317.2% | 804,776 | +159.8% | 0.22% | +366.7% |
| Q1 2018 | $9,510,000 | +4052.8% | 309,759 | +2367.4% | 0.05% | +4700.0% |
| Q4 2017 | $229,000 | -86.1% | 12,554 | -90.8% | 0.00% | -90.0% |
| Q3 2017 | $1,643,000 | – | 136,952 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Avoro Capital Advisors LLC | 1,000,000 | $31,470,000 | 8.67% |
| Baker Brothers Advisors | 2,805,074 | $88,276,000 | 0.77% |
| Broadfin Capital, LLC | 359,661 | $11,319,000 | 0.61% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 397,660 | $12,514,000 | 0.42% |
| Boulegeris Investments, Inc. | 17,415 | $548,000 | 0.39% |
| SPHERA FUNDS MANAGEMENT LTD. | 95,000 | $2,990,000 | 0.29% |
| Rhenman & Partners Asset Management AB | 50,000 | $1,574,000 | 0.19% |
| Integre Asset Management, LLC | 23,996 | $755,000 | 0.16% |
| Orbimed Advisors | 680,500 | $21,415,000 | 0.16% |
| EAM Investors, LLC | 38,754 | $1,220,000 | 0.14% |